01—Abstract
Summary
Summary of the 10-K filed March 15, 2004. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group's 2003 Form 10-K (filed March 15, 2004) shows a very strong year: revenues rose 15% to $28.8 billiona, earnings from operations climbed 34% to $2.9 billion, and net earnings reached $1.8 billion, up 35%.
Diluted EPS was $2.96b, up 39% from $2.13. The consolidated medical care ratio improved to 81.4% from 83.0%, and the operating cost ratio fell to 16.9% from 17.5%, driving the consolidated operating margin up to 10.2% from 8.7%. Return on shareholders' equity was 39.0%.
Growth was broad-based: Health Care Services (UnitedHealthcare, Ovations, AmeriChoice) earnings rose 40%, while Uniprise, Specialized Care Services and Ingenix also grew. The balance sheet expanded substantially through acquisitions. Golden Rule Financial was acquired in November 2003 for $495 millionc in cash, and Mid Atlantic Medical Services (MAMSI) was acquired in February 2004 for roughly $2.7 billion, paid in 36.4 million shares plus about $800 million in cash.
Total assets rose to $17.6 billiond and debt totaled $2.0 billion, with a debt-to-total-capital ratio of 27.8%, which management intends to keep at or below 30%. The company repurchased 33 million shares for about $1.6 billion during 2003 and still has authorization for 45 million more. Investors should weigh several risks.
Management notes that a 1% change in commercial medical costs would move net earnings by about $75 million. Ovations depends on the AARP contract, which generated about $4.1 billion in premium revenue.
The company also faces ongoing managed care class-action litigation, including the In Re Managed Care Litigation (MDL 1334) with a trial set for September 2004, and the AMA suit. Management states these are not expected to be materially adverse, but outcomes remain uncertain.
02—Key points
Key Highlights
- Revenue grew 15% to $28.8B and earnings from operations grew 34% to $2.9B in 2003.
- Diluted EPS of $2.96 was up 39% year over year; net earnings reached $1.825B, up 35%.
- Consolidated medical care ratio improved to 81.4% from 83.0%, while operating cost ratio fell to 16.9% from 17.5%.
- Return on shareholders' equity was 39.0%, up from 33.0%, with operating cash flow of $3.0B (up 24%).
- Acquired Golden Rule ($495M cash, Nov 2003) and MAMSI (~$2.7B, Feb 2004), expanding UnitedHealthcare's individual and mid-Atlantic footprint.
- Repurchased 33M shares (~$1.6B) in 2003; debt-to-total-capital at 27.8% with a stated target of 30% or less.
- Key risks include medical cost sensitivity (~$75M per 1% move), AARP contract dependence ($4.1B premiums), and ongoing managed care litigation with a September 2004 trial date.
03—Questions
Frequently Asked Questions
What drove UnitedHealth Group's earnings growth in 2003?
Earnings growth came from premium rate increases of roughly 12-13% on commercial risk-based business, improved medical care ratios (81.4% vs. 83.0%), operating cost efficiencies from technology and process improvements, and a shift toward higher-margin fee-based products. Health Care Services earnings rose 40%, and the company also benefited from the AmeriChoice acquisition in September 2002.
How significant are the MAMSI and Golden Rule acquisitions?
MAMSI, closed February 2004, cost about $2.7 billion in stock and cash and strengthens UnitedHealthcare's mid-Atlantic market position. Pro forma 2003 revenue would have been $31.5B and diluted EPS $3.02. Golden Rule, acquired November 2003 for $495M, adds about 430,000 individual members and a dedicated individual-market business. Both acquisitions added goodwill and intangibles, which increase future impairment risk.
What are the main risks to UnitedHealth's profitability?
The largest risk is medical cost inflation relative to premium pricing, since premiums are fixed for about 12 months. A 1% change in commercial medical costs would shift net earnings by about $75 million. Other risks include dependence on the AARP contract, evolving Medicare and Medicaid regulation, government investigations, intense competition, and the managed care class-action lawsuits, which management believes will not have a material adverse effect.
Is UnitedHealth's balance sheet and capital position sound?
Yes. Cash and investments totaled $9.5 billion, shareholders' equity was $5.1 billion, and debt was $2.0 billion with a 27.8% debt-to-capital ratio. Senior debt is rated A by S&P and Fitch and A3 by Moody's. Regulated subsidiaries held about $3.1 billion of statutory capital. The company has $900 million in credit facilities supporting commercial paper and remained in covenant compliance.
What is the company doing with excess cash?
In 2003 UnitedHealth returned capital mainly through share repurchases, buying back 33 million shares for about $1.6 billion, and paid a modest dividend of $0.015 per share. It also funded acquisitions, including Golden Rule and MAMSI. The board has authorized up to 45 million additional shares for repurchase, and management describes the program as discretionary.
04—Continue